The PanACEA Annual Meeting was followed by a day of seminars, which was open to all PanACEA participants. The PanACEA Consortium Coordination and Finance Expertise Core organized a Financial Workshop where Rutger Spoor, Wendy Simons and Jaco Swart trained the participants in several components of Financial Management en Financial Reporting. Main subjects were managing en…
The General Assembly of PanACEA gathered in Cape Town, South Africa, on the 28th of February and the 1st of March 2018 for the second Annual Meeting of PanACEA II. Over 80 delegates from Tanzania, South Africa, Germany, Gabon, The Netherlands, UK, Malawi, Switzerland, Mozambique and Uganda were present, together representing all PanACEA institutions. Special…
Read more PanACEA General Assembly Annual Meeting II Cape Town
Thursday 22nd and Friday 23rd of February the Instituto Nacional de Saude (INS) welcomed a delegation existing of Martin Boeree, Lindsey te Brake, Rutger Spoor (Radboudumc), Lavinia Rodney, Robert Hunt (UCL) and Sarah Konsten (LMU), for the very first PanACEA II site visit. Overall the feedback of the delegation was very positive and the site…
The PanACEA consortium assembled for their quarterly meeting 11th of December. As last time, the main agenda item was the progress of the Core Expertise Teams. The Core Teams are assigned to different areas of expertise related to trial conduct: Sponsor Responsibility and Trial Management, Drug Management, Clinical Pharmacology, Trial design and Statistics, Microbiology Lab,…
The global news network Euronews Television has made a 12-minute documentary about the PanACEA mission and the fight against TB. The documentary will be broadcasted on the Euronews channel, website and social networks. The Euronews team beautifully portrayed the PanACEA project, the partner institutions in Malawi and Tanzania, and the researchers and patients involved. The documentary…
Read more Euronews TV reports about PanACEA and the fight against TB
The General Assembly’s quarterly meeting took place 25th of September. PanACEA assembled with representatives from the vast majority of the consortium partners. On behalf of the Executive Group the coordinator informed the General Assembly on PanACEA’s progress. This meeting particularly covered the start-up of the Core Expertise Teams. The Cores will serve as operational support…
The PanACEA Executive group has returned to Amsterdam on the 26th of September to meet with representatives from South Africa, Tanzania, the UK, Germany and the Netherlands. PanACEA II has started its first trial, HIGHRIF, and is moving towards the phase IIA study; an excellent moment to discuss the latest developments in a face-to-face meeting.…
As preparation for the teleconference that the PanACEA General Assembly will hold in June, the project’s Executive Group met in Amsterdam to discuss its plans, and upcoming deliverables and milestones on May 12th, 2017. The Executive Group met with representatives from Tanzania, South Africa, the UK, Germany, and the Netherlands. Collaborations, publications, and capacity development…
On 7 and 8 March 2017, the PanACEA consortium had their kick-off meeting in the sunny Cape Town in South Africa. A staggering number of 73 people attended the first day of the meeting. Important topics were the trials in the first two work packages, and PanACEA’s governance. Furthermore, time was set out for several partners…
Rob Aarnoutse, Leon van Halder, and Martin Boeree signing the PanACEA II Grant Agreement PanACEA II has been granted 16.5 million euro in their drug development programme to shorten and simplify treatment of tuberculosis. On February 24th 2017, the coordinating team from Radboudumc Nijmegen, Martin Boeree and Rob Aarnoutse, have signed the PanACEA Grant Agreement…
